Pre-treatment Metabolic Tumor Volume and Total Lesion Glycolysis are Useful Prognostic Factors for Esophageal Squamous Cell Cancer Patients |
Li, Yi-Min
(Department of Radiation Oncology, the First Affiliated Hospital of Xiamen University)
Lin, Qin (Department of Radiation Oncology, the First Affiliated Hospital of Xiamen University) Zhao, Long (Department of Nuclear Medicine, the First Affiliated Hospital of Xiamen University) Wang, Li-Chen (Department of Radiation Oncology, the First Affiliated Hospital of Xiamen University) Sun, Long (Department of Nuclear Medicine, the First Affiliated Hospital of Xiamen University) Dai, Ming-Ming (Department of Radiation Oncology, the First Affiliated Hospital of Xiamen University) Luo, Zuo-Ming (Department of Nuclear Medicine, the First Affiliated Hospital of Xiamen University) Zheng, Hua (Department of Radiation Oncology, the First Affiliated Hospital of Xiamen University) Wu, Hua (Department of Nuclear Medicine, the First Affiliated Hospital of Xiamen University) |
1 | Westerterp M, Sloof GW, Hoekstra OS, et al (2008). 18FDG uptake in oesophageal adenocarcinoma: linking biology and outcome. J Cancer Res Clin Oncol, 134, 227-36. DOI ScienceOn |
2 | Roedl JB, Colen RR, Holalkere NS, et al (2008). Adenocarcinomas of the esophagus: response to chemoradiotherapy is associated with decrease of metabolic tumor volume as measured on PET-CT. Comparison to histopathologic and clinical response evaluation. Radiother Oncol, 89, 278-86. DOI ScienceOn |
3 | Liao S, Penney BC, Zhang H, Suzuki K, Pu Y (2012). Metabolic Tumor Volume Measured by F-18 FDG PET/CT can Further Stratify the Prognosis of Patients with Stage IV Non-Small Cell Lung Cancer. Nucl Med Mol Imaging, 19, 69-77. |
4 | Weber WA, Ziegler SI, Thodtmann R, Hanauske AR, Schwaiger M (1999). Reproducibility of metabolic measurements in malignant tumors using FDG PET. J Nucl Med, 40, 1771-7. |
5 | Zhu WQ, Sun XR (2011). The prognostic value of metabolic tumor volume in FDG PET/CT evaluation of post-operative survival in patients with esophageal squamous cell cancer[in Chinese]. Chin J Nucl Med, 31, 378-81. |
6 | Hong D, Lunagomez S, Kim EE, et al (2005). Value of baseline positron emission tomography for predicting overall survival in patient with nonmetastatic esophageal or gastroesophageal junction carcinoma. Cancer, 104, 1620-6. DOI ScienceOn |
7 | Greene FL (2002). The American Joint Committee on Cancer: updating the strategies in cancer staging. Bull Am Coll Surg, 87, 13-5. |
8 |
Hellwig D, Graeter TP, Ukena D, et al (2007). |
9 | Herskovic A, Martz K, al-Sarraf M, et al (1992). Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med, 326, 1593-8. DOI ScienceOn |
10 | Hyun SH, Choi JY, Shim YM, et al (2010). Prognostic value of metabolic tumor volume measured by 18F-fluorodeoxyglucose positron emission tomography in patients with esophageal carcinoma. Ann Surg Oncol, 17, 115-22. DOI ScienceOn |
11 | Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. DOI |
12 | Klaeser B, Nitzsche E, Schuller JC, et al (2009). Limited predictive value of FDG-PET for response assessment in the preoperative treatment of esophageal cancer: results of a prospective multi-center trial (SAKK 75/02). Onkologie, 32, 724-30. DOI ScienceOn |
13 | Omloo JM, Sloof GW, Boellaard R, et al (2008). Importance of fluorodeoxyglucose-positron emission tomography (FDG-PET) and endoscopic ultrasonography parameters in predicting survival following surgery for esophageal cancer. Endoscopy, 40, 464-71. DOI ScienceOn |
14 | Rizk N, Downey RJ, Akhurst T, et al (2006). Preoperative 18[F]-fluorodeoxyglucose positron emission tomography standardized uptake values predict survival after esophageal adenocarcinoma resection. Ann Thorac Surg, 81, 1076-81. DOI ScienceOn |
15 | Bradley J, Thorstad WL, Mutic S, et al (2004). Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys, 59, 78-86. DOI ScienceOn |
16 | Cooper JS, Guo MD, Herskovic A, et al (1999). Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA, 281, 1623-7. |
17 |
Shen K, Huang XE, Lu YY, et al (2012). Phase II study of docetaxel (Aisu |
18 | Ma JB, Chen EC, Song YP, et al (2013). Prognostic significance of 18F-fluorodeoxyglucose positron emission tomography (PET)-based parameters in neoadjuvant chemoradiation treatment of esophageal carcinoma. Asian Pac J Cancer Prev, 14, 2477-81. 과학기술학회마을 DOI ScienceOn |
![]() |